Valsartan reduces level of soluble ST2 and left ventricle remodeling in patients with dual chamber pacemaker
31 August 2019 (11:00 - 16:00)
Organised by:
Abstract
About the speaker
Specialist Hospital in Zabrze, Zabrze (Poland)
9 More presentations in this session
Access the full session
The Event
ESC Congress 2019
31 August 2019
11:00 CET
You may be interested in
Congress Session
